Biodyne Co. Ltd.
Biodyne Co., Ltd. engages in the development, manufacture, and sale of liquid-based cytology (LBC) equipment and reagent kits for cancer diagnosis in South Korea. The company offers PATHPLORER solution, which preserves and fixes the collected cells; PATHPLORER LBC system, an equipment for processing liquid cytology samples for cancer diagnosis. It exports its products to Japan, Russia, Portugal, … Read more
Biodyne Co. Ltd. (314930) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.007x
Based on the latest financial reports, Biodyne Co. Ltd. (314930) has a cash flow conversion efficiency ratio of 0.007x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩303.37 Million) by net assets (₩42.67 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Biodyne Co. Ltd. - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Biodyne Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Biodyne Co. Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biodyne Co. Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chien Kuo Construction Co Ltd
TW:5515
|
0.015x |
|
Vuzix Corp Cmn Stk
NASDAQ:VUZI
|
-0.132x |
|
PLAYTIKA HOLDING DL-01
F:8II
|
N/A |
|
SmarTone Telecommunications Holdings Limited
PINK:STTFF
|
0.003x |
|
Namchow Food Group (Shanghai) Co. Ltd.
SHG:605339
|
-0.011x |
|
Voxel S.A.
WAR:VOX
|
0.115x |
|
Ganesha Ecosphere Limited
NSE:GANECOS
|
0.074x |
|
Tracsis plc
PINK:TCIIF
|
0.110x |
Annual Cash Flow Conversion Efficiency for Biodyne Co. Ltd. (2018–2024)
The table below shows the annual cash flow conversion efficiency of Biodyne Co. Ltd. from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩43.20 Billion | ₩877.41 Million | 0.020x | +117.55% |
| 2023-12-31 | ₩43.38 Billion | ₩405.03 Million | 0.009x | -84.06% |
| 2022-12-31 | ₩44.16 Billion | ₩2.59 Billion | 0.059x | +546.63% |
| 2021-12-31 | ₩38.50 Billion | ₩-504.73 Million | -0.013x | -179.33% |
| 2020-12-31 | ₩7.00 Billion | ₩115.72 Million | 0.017x | -97.41% |
| 2019-12-31 | ₩6.58 Billion | ₩4.20 Billion | 0.639x | -49.09% |
| 2018-12-31 | ₩422.25 Million | ₩530.11 Million | 1.255x | -- |